MX9707009A - Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women. - Google Patents
Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women.Info
- Publication number
- MX9707009A MX9707009A MX9707009A MX9707009A MX9707009A MX 9707009 A MX9707009 A MX 9707009A MX 9707009 A MX9707009 A MX 9707009A MX 9707009 A MX9707009 A MX 9707009A MX 9707009 A MX9707009 A MX 9707009A
- Authority
- MX
- Mexico
- Prior art keywords
- perimenopausal
- injectable
- month
- once
- useful
- Prior art date
Links
- 230000002254 contraceptive effect Effects 0.000 title abstract 3
- 239000003433 contraceptive agent Substances 0.000 title abstract 2
- 238000002657 hormone replacement therapy Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000000262 estrogen Substances 0.000 abstract 2
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 206010030247 Oestrogen deficiency Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A once-a-month-injectable that contains an oestrogen and a gestagen component as active substances is used to prepare a contraceptive medicament useful at the same time in the hormone replacement therapy for perimenopausal and premenopausal women. A reliable contraceptive effect with a "natural" oestrogen (without ethinyl oestradiol) is achieved with this medicament, as well as an effective therapy of the first oestrogen deficiency symptoms and the prevention of osteoporosis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19510861A DE19510861A1 (en) | 1995-03-16 | 1995-03-16 | One-month injection as a depot contraceptive and for hormone replacement therapy for peri- and premenopausal women |
| PCT/EP1996/001201 WO1996028165A1 (en) | 1995-03-16 | 1996-03-15 | Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9707009A true MX9707009A (en) | 1997-11-29 |
Family
ID=7757668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9707009A MX9707009A (en) | 1995-03-16 | 1996-03-15 | Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0814811A1 (en) |
| JP (1) | JPH11501649A (en) |
| KR (1) | KR19980703058A (en) |
| AR (1) | AR002283A1 (en) |
| AU (1) | AU713258B2 (en) |
| CA (1) | CA2215382A1 (en) |
| CZ (1) | CZ289697A3 (en) |
| DE (1) | DE19510861A1 (en) |
| HU (1) | HUP9801691A3 (en) |
| IL (1) | IL117516A (en) |
| MX (1) | MX9707009A (en) |
| NO (1) | NO974255L (en) |
| NZ (1) | NZ304027A (en) |
| PL (1) | PL322202A1 (en) |
| SK (1) | SK123997A3 (en) |
| WO (1) | WO1996028165A1 (en) |
| ZA (1) | ZA962177B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
| KR20250142811A (en) * | 2024-03-22 | 2025-09-30 | 주식회사 에아스텍 | Use of Norethisterone enanthate compound for preventing or treating a cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
-
1995
- 1995-03-16 DE DE19510861A patent/DE19510861A1/en not_active Withdrawn
-
1996
- 1996-03-15 CZ CZ972896A patent/CZ289697A3/en unknown
- 1996-03-15 AU AU51108/96A patent/AU713258B2/en not_active Ceased
- 1996-03-15 NZ NZ304027A patent/NZ304027A/en not_active IP Right Cessation
- 1996-03-15 CA CA002215382A patent/CA2215382A1/en not_active Abandoned
- 1996-03-15 KR KR1019970706467A patent/KR19980703058A/en not_active Ceased
- 1996-03-15 MX MX9707009A patent/MX9707009A/en not_active IP Right Cessation
- 1996-03-15 AR ARP960101766A patent/AR002283A1/en unknown
- 1996-03-15 EP EP96907506A patent/EP0814811A1/en not_active Withdrawn
- 1996-03-15 PL PL96322202A patent/PL322202A1/en unknown
- 1996-03-15 SK SK1239-97A patent/SK123997A3/en unknown
- 1996-03-15 JP JP8527295A patent/JPH11501649A/en not_active Ceased
- 1996-03-15 WO PCT/EP1996/001201 patent/WO1996028165A1/en not_active Ceased
- 1996-03-15 HU HU9801691A patent/HUP9801691A3/en unknown
- 1996-03-17 IL IL11751696A patent/IL117516A/en not_active IP Right Cessation
- 1996-03-18 ZA ZA962177A patent/ZA962177B/en unknown
-
1997
- 1997-09-15 NO NO974255A patent/NO974255L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE19510861A1 (en) | 1996-09-19 |
| AR002283A1 (en) | 1998-03-11 |
| KR19980703058A (en) | 1998-09-05 |
| JPH11501649A (en) | 1999-02-09 |
| ZA962177B (en) | 1996-07-29 |
| EP0814811A1 (en) | 1998-01-07 |
| SK123997A3 (en) | 1998-02-04 |
| CZ289697A3 (en) | 1997-12-17 |
| IL117516A0 (en) | 1996-07-23 |
| PL322202A1 (en) | 1998-01-19 |
| NO974255L (en) | 1997-11-14 |
| IL117516A (en) | 2000-07-26 |
| NO974255D0 (en) | 1997-09-15 |
| AU713258B2 (en) | 1999-11-25 |
| NZ304027A (en) | 2000-05-26 |
| HUP9801691A3 (en) | 1999-03-01 |
| AU5110896A (en) | 1996-10-02 |
| CA2215382A1 (en) | 1996-09-19 |
| WO1996028165A1 (en) | 1996-09-19 |
| HUP9801691A2 (en) | 1998-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ234051A (en) | Treating post-menopausal disorders using an estrogenic compound mixed with a compound having progestational activity | |
| DE69710896D1 (en) | Progestogen-anti-progestogen therapien | |
| PL327182A1 (en) | Method of preventing conception among female mammals through combined application of gestagen and oestrogen and combination of active agent therefor | |
| BG104451A (en) | Antiestrogen and progestin-containing peroral contraceptives | |
| IL122109A0 (en) | A two-stage pharmaceutical preparation for hormonal contraception and a kit containing the same | |
| UA41401C2 (en) | Pharmaceutical combined contraceptive agent | |
| EP1935423A3 (en) | Composition for treating and/or prophylaxis of tumors of the breast | |
| KR960700727A (en) | HORMONE REPLACEMENT THERAPY | |
| GR970100477A (en) | Novel formulation | |
| BG101349A (en) | Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy | |
| MY108866A (en) | Contraception method using competitive progesterone antagonists and novel compounds useful therein | |
| LU90341I2 (en) | 75 Ug desogestrel in the absence of ethinyl estradiol (cerazette) | |
| WO1994002103A3 (en) | Ovulation inhibitor for hormonal contraception | |
| MX9707009A (en) | Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women. | |
| UA41351C2 (en) | Contraception method and tablets for contraception | |
| CA2248841A1 (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| GD | Licence granted | ||
| HC | Change of company name or juridical status |
Owner name: PFIZER IRELAND PHARMACEUTICALS |
|
| MM | Annulment or lapse due to non-payment of fees |